About ActivX
ActivX is a Healthcare company based in San Diego (United States) founded in 2000, and was acquired by KYORIN Pharmaceutical in December 2004. Developer of kinase and protease targeted drugs for oncology, hematology, and metabolic diseases. The company has 28 employees. Its chief executive, as recorded, is Hugh Rosen. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Proteomics. Its legal entity is ACTIVX BIOSCIENCES, INC. Its competitors include Nautilus Biotechnology, Somalogic and ProteinSimple; 3 of its 3 listed competitors have raised funding.
Company details
Activx Biosciences is focussed on developing small molecule drugs for the range of indications. It applies its proprietary chemical technologies and high-throughput protein analysis to identify the target- and off-target activities of drug candidates in the protein kinase and protease families with a focus on the areas of oncology, hematology, metabolic and inflammatory diseases. Its current focus in on oncology and is targeting the ATP- and GTP-utilizing enzymes, such as protein kinases and G-proteins. Its lead candidate, KRP-104, is a dipeptidyl peptidase-4 (DPP-4) inhibitor, for the treatment of type 2 diabetes, which in late-stage clinical trials.
- Headquarters San Diego, United States
- Employees 28
- Stage Acquired
- SectorsHealthcare
- Website activx.com
- Social LinkedIn Facebook
- Acquired by KYORIN Pharmaceutical (Dec 2004)
- Legal Name Activx Biosciences, Inc.
- Latest Funding Round$1.1M (USD), Grant
Jun 2003
- InvestorsSBIR
& 1 more
- Employee Count28
- Acquired byKYORIN Pharmaceutical
(Dec 2004)
Funding Insights of ActivX
- Total Rounds 2
- Last Round Grant — $1.1M
- First Round $155,000
(Aug 2002)
- Investors Count 1
All 2 funding rounds of ActivX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in ActivX
ActivX has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include SBIR and KYORIN Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States | |
Pharmaceuticals are manufactured and sold by KYORIN Pharmaceutical. | 1923 | kyorin-pharm.co.jp | Chiyoda City, Japan |
Investor details for ActivX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ActivX
1 people are tracked at ActivX (1 in leadership); the tracked headcount is 28.
| Name | Role | Group |
|---|---|---|
Hugh Rosen | Chairman & CEO | Leadership |
Complete people profiles for ActivX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ActivX
4 dated milestones of ActivX across 4 years, from founding to its latest funding, stage changes and deals.
- Founded ActivX is founded.
- Funding First funding round of $155K.
- Funding Latest funding round, Grant, of $1.1M.
- Exit Acquired by KYORIN Pharmaceutical.
Competitors of ActivX
ActivX has 3 listed competitors in our database, 3 of them funded. They include Nautilus Biotechnology, Somalogic and ProteinSimple.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nautilus.bio | 2016 | Seattle, United States | $103.26M | 134 | A proteomics platform is developed for analyzing the human proteome. | |
| somalogic.com | 1999 | Boulder, United States | $663.99M | 319 | Protein-based assays are developed for life science research. | |
| proteinsimple.com | 2004 | San Jose, United States | $114.29M | 157 | Provider tools to help researchers with protein analysis |
Detailed competitors of ActivX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ActivX
Websites that share an audience with ActivX (activx.com).
Websites whose visitors overlap most with ActivX. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
download.cnet.com | download.cnet.com | 100% | #13,746 | – | |
| microsoft.com | 96% | 1.2B | #33 | View details | |
| arraybiopharma.com | 69% | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as ActivX (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Activx
Complete news archive for ActivX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ActivX
ActivX was founded in 2000 and raised its 1st funding round 2 years after it was founded.
ActivX is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Hugh Rosen is the CEO of ActivX, as recorded in our data.
ActivX has 28 employees.
Activx Biosciences is focussed on developing small molecule drugs for the range of indications. It applies its proprietary chemical technologies and high-throughput protein analysis to identify the target- and off-target activities of drug candidates in the protein kinase and protease families with a focus on the areas of oncology, hematology, metabolic and inflammatory diseases. Its current focus in on oncology and is targeting the ATP- and GTP-utilizing enzymes, such as protein kinases and G-proteins. Its lead candidate, KRP-104, is a dipeptidyl peptidase-4 (DPP-4) inhibitor, for the treatment of type 2 diabetes, which in late-stage clinical trials.
ActivX's top competitors include Somalogic, Nautilus Biotechnology and ProteinSimple.
ActivX has 2 investors. Key investors include SBIR, and KYORIN Pharmaceutical.
ActivX operates through Activx Biosciences, Inc..
Yes. ActivX was acquired by KYORIN Pharmaceutical in December 2004.